Basit öğe kaydını göster

dc.contributor.authorSonmezoglu, K.
dc.contributor.authorHalac, M.
dc.contributor.authorSayman, H. B.
dc.contributor.authorSager, S.
dc.contributor.authorAsa, S.
dc.contributor.authorVatankulu, B.
dc.contributor.authorAksoy, S. Yilmaz
dc.date.accessioned2021-03-05T19:46:12Z
dc.date.available2021-03-05T19:46:12Z
dc.date.issued2016
dc.identifier.citationVatankulu B., Aksoy S. Y. , Asa S., Sager S., Sayman H. B. , Halac M., Sonmezoglu K., "Accuracy of FDG-PET/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes", REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, cilt.35, ss.17-21, 2016
dc.identifier.issn2253-654X
dc.identifier.otherav_d0d1c018-39ae-4323-8669-4a3437f908e8
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/138043
dc.identifier.urihttps://doi.org/10.1016/j.remn.2015.07.001
dc.description.abstractObjective: There is still no consensus about whether to perform PET/CT to detect carcinoma in paraneoplastic neurological syndromes (PNS) in patients with or without antibodies. The aim of this study is to determine the diagnostic accuracy of PET/CT and antibodies in patients with PNS.
dc.language.isoeng
dc.subjectNükleer Tıp
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectRADYOLOJİ, NÜKLEER TIP ve MEDİKAL GÖRÜNTÜLEME
dc.titleAccuracy of FDG-PET/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes
dc.typeMakale
dc.relation.journalREVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume35
dc.identifier.issue1
dc.identifier.startpage17
dc.identifier.endpage21
dc.contributor.firstauthorID228179


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster